Dangerous Drugs & Devices Archives

GM UNDER INVESTIGATION FOR RECENT RECALL OF MODELS WITH FAULTY IGNITION SWITCH

Last month, General Motors recalled the 2007 Pontiac G5 and Chevrolet Cobalts manufactured from 2005-2007 due to faulty ignition switches – which according to the New York Times caused these models to shut off in cases of “a heavy key ring or a ‘jarring event’ such as running off the road.”

CONSUMER REPORT FINDS CHILDREN’S PRODUCTS RECALLS LARGELY INEFFECTIVE

According to Chicago-based group Kids in Danger (KID), only 10% recalled children’s products were ever fixed or destroyed after the recall in 2012.

FDA TO INVESTIGATE DIABETES DRUG SAXAGLIPTIN

The Food and Drug administration recently announced that it will investigate the diabetes drug, Saxagliptin to determine if patients have an increased risk of heart failure while using the drug.

EDITORIAL INDICATES TESTOSTERONE MAY BE OVERSOLD IN THE U.S.

On February 4, 2014, the New York Times published an editorial indicating that drugs used to treat a medical condition known as “low T” are possibly being oversold in the U.S.

STUDY FINDS LINK BETWEEN TESTOSTERONE THERAPY AND SERIOUS HEALTH CONCERNS

In November 2013, the Journal of the American Medical Association (JAMA) published the results of a study that sought to understand the relationship between testosterone therapy intake and health issues in men, particularly heart attack and stroke.

FDA issues safety announcement regarding health risks associated with testosterone products

On January 31, 2014, the U.S. Food and Drug Administration (FDA) issued a safety alert indicating the agency will investigate whether an association exists between the use of FDA-approved testosterone products and the increased risk of stroke, heart attack and death in men.

Free Consultation
Call Now

Dangerous Drugs & Devices

GM UNDER INVESTIGATION FOR RECENT RECALL OF MODELS WITH FAULTY IGNITION SWITCH

CONSUMER REPORT FINDS CHILDREN’S PRODUCTS RECALLS LARGELY INEFFECTIVE

FDA TO INVESTIGATE DIABETES DRUG SAXAGLIPTIN

EDITORIAL INDICATES TESTOSTERONE MAY BE OVERSOLD IN THE U.S.

STUDY FINDS LINK BETWEEN TESTOSTERONE THERAPY AND SERIOUS HEALTH CONCERNS

FDA issues safety announcement regarding health risks associated with testosterone products

HPV VACCINE: DOES THE RISK OUTWEIGH THE BENEFIT?

FDA ANNOUNCES IMPROVEMENTS TO MEDICAL DEVICE RECALL DATABASE

DEPUY ASR SETTLEMENT UPDATE

DEPUY ASR SETTLEMENT PROGRAM ANNOUNCED

Hurt in a dangerous drugs & devices situation?

FREE CASE EVALUATION

Main Office

E-mail

Phone

FREE CASE EVALUATION

Main Office

E-mail

Phone

Practice Areas

Connect With Us